Work

Fibroblast growth factor receptor 3 ( FGFR3 ) alteration status and outcomes with immune checkpoint inhibitors (ICPI) in patients with metastatic urothelial carcinoma.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.4564

Authors: Shilpa Gupta, Jessica Lee, Jerry W. Mitchell, Richard Sheng Poe Huang

Institutions: Cleveland Clinic, Foundation Medicine (United States)

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410822867

Cites:

Cited by:

Related to: 10